Distinct repeat motifs at the C-terminal region of CagA of Helicobacter pylori strains isolated from diseased patients and asymptomatic individuals in West Bengal, India by Chattopadhyay, Santanu et al.
Chattopadhyay et al. Gut Pathogens 2012, 4:4
http://www.gutpathogens.com/content/4/1/4RESEARCH Open AccessDistinct repeat motifs at the C-terminal region
of CagA of Helicobacter pylori strains isolated
from diseased patients and asymptomatic
individuals in West Bengal, India
Santanu Chattopadhyay1, Rajashree Patra1, Raghunath Chatterjee1, Ronita De1, Jawed Alam1, T. Ramamurthy1,
Abhijit Chowdhury2, G. Balakrish Nair1, Douglas E. Berg3 and Asish K. Mukhopadhyay1,4*Abstract
Background: Infection with Helicobacter pylori strains that express CagA is associated with gastritis, peptic ulcer
disease, and gastric adenocarcinoma. The biological function of CagA depends on tyrosine phosphorylation by a
cellular kinase. The phosphate acceptor tyrosine moiety is present within the EPIYA motif at the C-terminal region
of the protein. This region is highly polymorphic due to variations in the number of EPIYA motifs and the
polymorphism found in spacer regions among EPIYA motifs. The aim of this study was to analyze the
polymorphism at the C-terminal end of CagA and to evaluate its association with the clinical status of the host in
West Bengal, India.
Results: Seventy-seven H. pylori strains isolated from patients with various clinical statuses were used to
characterize the C-ternimal polymorphic region of CagA. Our analysis showed that there is no correlation between
the previously described CagA types and various disease outcomes in Indian context. Further analyses of different
CagA structures revealed that the repeat units in the spacer sequences within the EPIYA motifs are actually more
discrete than the previously proposed models of CagA variants.
Conclusion: Our analyses suggest that EPIYA motifs as well as the spacer sequence units are present as distinct
insertions and deletions, which possibly have arisen from extensive recombination events. Moreover, we have
identified several new CagA types, which could not be typed by the existing systems and therefore, we have
proposed a new typing system. We hypothesize that a cagA gene encoding higher number EPIYA motifs may
perhaps have arisen from cagA genes that encode lesser EPIYA motifs by acquisition of DNA segments through
recombination events.
Keywords: Helicobacter pylori, CagA, Duodenal ulcerBackground
The gastric pathogen Helicobacter pylori chronically in-
fect more than half of human population. Although
most infections are asymptomatic, 10-15 % of the H. pyl-
ori infected individuals develop chronic inflammation
leading to atrophic gastritis, peptic ulcer as well as* Correspondence: asish_mukhopadhyay@yahoo.com
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distribution, and reproduction in any mediumgastric adenocarcinoma [1,2].This pathogen was classi-
fied as a type I carcinogen by the World Health
Organization in 1994. However, specific traits that en-
able a small proportion of this genetically diverse bacter-
ium in the pathogenesis are poorly understood. Early
studies showed that human convalescent sera collected
from diseased patients significantly respond to a high
molecular weight immunodominant bacterial protein
known as CagA [3–5]. Subsequently, it was found that
in western countries, H. pylori strains that express CagA
and specific vacuolating cytotoxin (VacA) subtypes areCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Prevalence of cagA subtypes obtained in Kolkata
and disease outcome
cagA types DU (N=40) Clinical statusHV (N=20) NUD (N=15)
Type B/D 31 (77.5 %) 17 (85 %) 10(66.6 %)
Type B/D 4 (10 %) 2 (10 %) 3 (20 %)
Type C 3 (7.5 %) 1 (5 %) 1 (6.7 %)
New types 2 (5 %) 0 (0 %) 1 (6.7 %)
* Two strains isolated from gastric carcinoma patients were not shown in the
table due to less sample size
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ingly, the expression of these virulence markers does not
seem to be similarly associated with the disease in Asian
context [11]. Although a series of hypotheses were re-
cently proposed the specific reason for the differences in
disease outcome and the biological function of the CagA
in gastric epithelium remained mostly unexplained.
The gene that encodes CagA is part of a ~40 kb hori-
zontally acquired DNA segment in the H. pylori genome
known as cag pathogenecity island (cagPAI) [8]. The cag-
PAI also contain genes encoding a type IV secretion sys-
tem, to ensure efficient translocation of the CagA protein
into the host epithelium [12–16]. After translocation,
CagA multimerizes and undergoes tyrosine phosphoryl-
ation by Src family kinases to its tyrosine moiety, which
resides in a repeat motif of five amino acids, glutamate-
proline-isoleusine-tyrosine-alanine (EPIYA), located at the
C-terminal region of the protein [17–20]. Phosphorylated
CagA binds to the Src homology 2 (SH2) domain of the
cellular phosphatase SHP-2, an important component of
the cell cycle regulation pathway. Due to the intrinsic
membrane tethering property of CagA the CagA-SHP-2
complex localizes to the plasma membrane of the host
epithelium [21], leading to disregulation of the SHP-2.
This event is necessary and sufficient to change the gastric
epithelium to a transformed epithelium, which is charac-
terized by altered cellular proliferation, migration and
elongated cell morphology known as hummingbird
phenotype [21,22]. The CagA also disrupts the tight junc-
tions and causes loss of apical-basolateral polarity in epi-
thelial cells [23,24].
The extent of biological activity of CagA is directly
associated with the number of phosphorylation sites or
the number of EPIYA motifs present at the C-terminal
region of CagA [21,25,26]. Due to these repeats, molecu-
lar weight of the CagA protein varies from 128–148 kDa
and the cagA gene shows extensive length polymorphism
at the 3’ end. Several attempts were made to type the
distinct CagA proteins and the cagA genes on the basis
of its length polymorphism at the C-terminal and 3'
ends, respectively [9,27–29]. The simplest method uses a
PCR to amplify the 3’ end of the gene to distinguish the
variations in the number and order of the EPIYA motif
coding regions [30]. In this PCR, it was found that the
“type A”, which gives ~642 bp amplicon and encodes
three EPIYA repeats is the most prevalent CagA type.
This type usually is not associated with the diseases. The
“Type C”, which yields ~810 bp product, encodes four
EPIYA repeats is associated with gastric adenocarcinoma
in Japan. Although this nomenclature is useful in terms
of assessing disease association of different CagA types,
the validity of this typing system in terms of disease as-
sociation and the prevalence of various CagA types have
not been tested in different geographic regions [31,32].Another typing method, which was used more often in
recent studies addressing the biological function of CagA
described the distribution of 5 EPIYA motifs as A-B-C-
C-C in CagA of strain NCTC11637 [33]. Mutational
analyses revealed that the first two EPIYA motifs (A and
B positions) have little, if any, biological function while
the other motifs (−C-C-C positions) are responsible for
the CagA phosphorylation and CagA-SHP-2 complex
formation, which leads to the hummingbird phenotype
[33]. Moreover, the amino acid sequences, which are
repeated among the third, fourth and fifth EPIYA motifs
(−C-C-C) differ among strains isolated from West and
East Asia. Accordingly, CagA was typed as Western-
CagA-specific sequences (WSS) and East Asian-CagA-
specific sequences (ESS) and this difference may account
for differences in disease outcome between the two geo-
graphical regions.
The present study aimed to address a number of issues.
First, we assessed the disease association with cagA 3'
end variations in Indian H. pylori strains, where the inci-
dence of gastric cancer is less but the incidence of duo-
denal ulcer is common. Second, the exact repeat units,
which form the spacer regions among the EPIYA motifs,
were determined to understand the precise mosaic struc-
ture of the CagA phosphorylation site repeat units. Fi-
nally, we have identified several new CagA types, which
could not be typed with the existing nomenclature and
this motivated us to propose a new typing system.Results
Prevalence of cagA types and clinical outcome
Fifty-eight (31 of 40 duodenal ulcer patients (DU), 17 of
20 healthy volunteers (HV), 10 of 15 non-ulcer dyspep-
tics (NUD) and one from gastric adenocarcinoma
patients (GC) of 77H. pylori strains included in this
study yielded a typical ~642 bp amplicon, designated as
type A by Yamaoka et al. (1998) (Table 1). PCR using
the same primer pair yielded ~756 bp amplicon corre-
sponding to type B/D for 9 strains (4 from DU, 2 from
HV and 3 from NUD) and ~810 bp amplicon corre-
sponding to type C for 5 strains (3 from DU, 1 from HV
and 1 from NUD) (Figure 1). Two strains from DU (I-
27i and PCR 98i) and one strain from GC (PCR 93ii)
Figure 1 Analysis of the 3' region of the cagA gene by PCR. PCR
products from a representative group of strains are shown. The sizes
of the DNA fragments were confirmed after sequencing of the PCR
products. Lane M, 100-bp molecular size markers.
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isolated from NUD (PCR 24) yielded the shortest ampli-
con (~450 bp) encountered in this study (Table 1). None
of these four short amplicons were described in the earl-
ier typing system. No disease association was found with
any of the CagA types. The expression of all CagA types
was confirmed by Western blot using anti-CagA antid-
ody (Figure 2). [The nucleotide sequences of the 3' end
of cagA gene of 21H. pylori strains were deposited in
GenBank under the following accession numbers:
EU089757 to EU089775, EU368669 and EU368670.]
Precise mosaic structure of the CagA
Nine representative strains with cagA type A (5 from
DU and 2 from HV and 1 each from CA and NUD), 6
strains with type B/D cagA (3 each from DU and HV), 2Figure 2 Western blot analysis of H. pylori strains expressing
representative CagA variants. H. pylori strains were grown on
brain heart infusion agar plates, harvested in PBS and subjected to
SDS-PAGE followed by western blot analysis using anti-CagA
antibody. Strain San 77, which carries CagA with five EPIYA motifs
and gave ~810 bp amplicon in PCR using primer CAG1/CAG2
expressed CagA protein with highest molecular weight (lane 1).
PCR98i and PCR24 which carry only two and single EPIYA motifs,
gave ~550 bp and ~450 bp amplicon respectively in the same PCR
expressed CagA proteins with much smaller size (lane 2 and 3).
These two strains expressed CagA proteins, which are smaller than
CagA expressed by strain San10 (lane 6) that carries 3 EPIYA motifs
and gave ~642 bp amplicon, although I-27i (lane 4), which also
carries two EPIYA motifsexpressed CagA protein with higher size
than PCR98i (lane 2). Strain I-80, which carries no cagA gene, was
used as negative control (lane 8).strains with cagA type C (1 each from DU and HV) and
4 strains (I-27i, PCR24, PCR93ii and PCR98i) that
yielded unusual amplicons were included in the se-
quence analysis. All the strains used in sequence analysis
carried Western-CagA-specific sequences (WSS). These
strains carried cagA genes capable of coding proteins
containing 1–5 EPIYA motifs. Further analysis of the
amino acid sequences predicted from nucleotide
sequences of cagA 3' end revealed several distinct fea-
tures present within EPIYA motifs.
To illustrate the discrete repeat units, a CagA protein
sequence (San 77) carrying the typical A-B-C-C-C type
EPIYA motifs (and WSS), which produced ~810 bp
amplicon with primers CAG1 and CAG2 was taken as
model (Figure 3). These short repeat units were detected
in CagA sequences of all the strains isolated from West
Bengal and Western Countries (those carrying WSS)
(Figure 4). The first EPIYA motif (termed as Y1 in this
study to denote tyrosine phosphorylation site) in this
CagA primary structure was preceded by a 10 amino
acids motif (S1) containing a stretch of 6 asparagines
(Figure 3). Irrespective of CagA types, this motif was
detected in all CagA proteins having WSS (Figure 4).
The first and the second EPIYA (termed as Y2) motifs
are separated by a motif named V1 that contains 13
amino acids. The V1 motif was found in all CagA
sequences included in this study that carry A-B-C or A-
B-C-C or A-B-C-C-C type EPIYA patterns. In agreement
to the previous report, no type D CagA carried similar
motif. Our analysis indicated that the absence of V1 and
Y2 in type D CagA is due to a specific deletion of this
locus (Figure 5b). Detection of several other deletions in
several other CagA types further supported this conno-
tation (Figure 5b).
Our analysis also indicates that the spacer regions of
third, fourth and fifth EPIYA (Y3, Y4 and Y5) motifs
contain several short discrete repeat motifs. The I1
motif was present immediately after the Y2 and was
never reappeared (Figure 4). This stretch was followed
by I2 and I3, which was present just before the Y3. As
shown in Figures 3 and 4, I2 and I3 were repeated in-
dependent of each other but always maintained their
respective positions and I2 was repeated one more
time than I3.
The Y3 is followed by another distinct motif, W1,
which is followed by I2 and I3 in A-B-C-C and A-B-C-
C-C type CagA. However, in A-B-C type CagA
(Figure 5B, strain PCR29i), though W1 and I2 were al-
ways present, I3 was replaced by another motif, T1. In
A-B-C-C-C type CagA, I3 is repeated 3 times along with
EPIYA motifs (at C positions) and after the last EPIYA
at C position (Y5), I3 was replaced by T1 (Figure 5b).
The comparative analysis of all the CagA primary struc-
tures revealed that T1, which must be present after I2
Figure 3 Repeat motifs at the C-terminal region of CagA of strain San77. Each motif was assigned with distinct colors. The first EPIYA motif
is preceded by a stretch of 10 amino acids containing 6 successive asparagines (motif S1). First and second EPIYA motifs (Y1 and Y2) were
connected by V1 region. The second EPIYA motif is followed by a motif called I1 and is never repeated while the sequence FPLKK—VGLS (motif
I2) was repeated four times. In motif I2, a single amino acid replacement was noticed in third and fourth repeats as compared to first and second
(shown with arrow). Third, fourth and fifth EPIYA motifs (Y3, Y4 and Y5) were always preceded and followed by I3 and W1 motifs. Remarkably,
after fifth EPIYA motifs (Y5) and fourth I2 motifs there are no I3 motif present and are replaced by motif T1, which represents the ‘stop’ signal for
this repeat region.
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repeat sequences and after T1 no EPIYA motif was
detected in any CagA primary structure.
The differences in PCR product sizes observed between
type C strains isolated from Japan and West Bengal wereFigure 4 Repeat motifs in Western (WSS) and Eastern (ESS) type CagA
while the I2 and W1 motifs are repeated (shown with arrow). However, in
regions homologous to I2 and W1 are not repeated.because the intact R3 region is repeated twice in ESS car-
rying CagA reported for Japanese H. pylori strains, while
CagA found in West Bengal (and also for all WSS carry-
ing CagA), only I2 and I3 is repeated but not I1. Another
important feature of WSS carrying CagA is W1. In WSS (NCTC 11637; reference 20), the I1 motif is not repeated,
ESS (see reference 42), the whole R3 region is repeated and the
Figure 5 (a) Alignment of nucleotide sequence of cagA 3' end repeat region of strain PCR 127i and I-230. Predicted amino acid sequence
was given at the bottom of the figure and motifs are represented as different colors. A 57 base deletion was observed in strain I-230, which
results in loss of 19 amino acids. These 19 amino acids include V1 and an EPIYA motif (Y2). (b) Identification of deletions observed in the repeat
region at the C-terminal of CagA of H. pylori strains isolated from India. Each motif was assigned a color and the regions deleted were shown in
dashed line.
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positions (Y3, Y4, Y5), while the sequence, which
replaces this motif in ESS CagA (TIDFGEANQAG) is
present only once, after the last EPIYA motif (Y3 for A-
B-C type, Y4 for A-B-C-C and Y5 for A-B-C-C-C type).
The motif in ESS CagA (FPLRRSAAVRDLSKVGLS),
which is homologous to I2, is also present only once, im-
mediately before T1.
Description of new CagA types and development of new
typing system
Our sequence analyses identified several new CagA pri-
mary structures, which could not be typed by previously
suggested typing system. The strains that gave unusual
~550 bp amplicons (PCR93ii and PCR98i) were found to
carry unique CagA primary structures. Interestingly, in
these two CagA primary structures, I3 and W1 regions
were missing. The entire sequence between the Y2 and
the T1 was also absent, possibly due to a deletion event
(Figure 5B). In other words, for these two CagA types,
EPIYA motifs were present at A and B positions only,
while there was no EPIYA motif at C position [33].
However, the strain I-27i, which yielded similar ~550 bp
amplicon contains entirely different CagA primarystructure. In this CagA, V1 and the adjacent EPIYA (Y2)
at B position were absent (Figure 5b). The shortest
amplicon (~450 bp) was obtained in this study with
strain PCR24. In this CagA, the S1 was followed by only
one EPIYA motif and then a big deletion was detected
as several repeat units such as V1, Y2, I1, I2, I3 and Y3
were entirely missing. Since previous typing systems
failed to type these CagA primary structures we suggest
a new typing system (Table 2).Natural insertion and deletions
Our analyses suggest that the distinct repeat motifs could
be present in the form of either deletion or insertion. To
further confirm this hypothesis, CagA from 2 strains
(San53 and PCR29i) could be taken as examples. As
shown in Figure 5, these two primary structures revealed
that only a portion of CagA sequence (W1I2I3Y4, shown
in underline and italics) in strain San53 was absent in
CagA primary structure of strain PCR 29i. In other
words, if the region W1I2I3Y4 could be inserted to CagA
primary structure of strain PCR 29i, between Y3 and W1
(shown in bold), both these strains would have similar
CagA.
Table 2 CagA primary structures commonly observed in India and in Western countries and the new typing system.
CagA primary structures Types described by
Yamaoka et al. (1998)
Types described by
Higashi et al. (2002)
New typing system
(this study)
Examples in
this study
S1Y1V1Y2I1I2I3Y3W1I2T1 Type A A-B-C Type 1 PCR29i
S1Y1V1Y2I1I2I3Y3W1I2I3Y4W1I2T1 Type C A-B-C-C Type 2 San53
S1Y1V1Y2I1I2I3Y3W1I2I3Y4W1I2I3Y5W1I2T1 Type ? A-B-C-C-C Type 3 San77
S1Y1I1I2I3Y3W1I2I3Y4W1I2T1 Type D A-C-C Type 4 I-230
S1Y1I1I2I3Y3W1I2T1 Type ? A-C (?) Type 5 I-27i
S1Y1W1I2T1 Type ? A (?) Type 6 PCR24
S1Y1V1Y2I1I2T1 Type ? A (?) Type 7 PCR98
Some of these types could not be addressed with previous systems and termed as “type ?”
Chattopadhyay et al. Gut Pathogens 2012, 4:4 Page 6 of 12
http://www.gutpathogens.com/content/4/1/4Analysis also revealed that strains (eg. I-230) carrying
previously described type D CagA actually has a deletion
of V1Y2 regions and if this region were inserted between
Y1 and I1 (shown in bold) they would have a CagA simi-
lar to that of type C (Figure 5a). Even more interesting
observations were obtained while analyzing CagA pri-
mary structure of strain I-27i where region W1I2I3Y4
was deleted. Although this strain gave an amplicon closer
to type A by PCR using primers CAG1 and CAG2, pri-
mary structure analysis revealed that this CagA was
closely related to type D and insertion of W1I2I3Y4 be-
tween Y3 and W1 (shown in bold) could make it exactly
similar to type D CagA (Figure 5b).
Further larger deletions in CagA were noticed in
strains PCR93ii and PCR98i. Both these strains had a de-
letion of I3Y3W1I2 between I2 and T1 (shown in bold).
Strain PCR24, which carry only one EPIYA motif, had
the largest deletion. The entire region between Y1 and
W1 (shown in bold) was deleted in this CagA and it was
not possible to predict from which type of CagA it has
evolved through deletion. On the other hand, it is pos-
sible that this CagA bears the core unit and the otherFigure 6 Schematic representation of various types of deletions or in
deleted or inserted are mentioned along with the arrows. The regions whe
type 2 and type 4 CagA, the V1Y2 motifs were inserted within Y1 and I1 an
in the diagram, almost all the types could be converted to the other typescomplex CagA structures have evolved from it
(Figure 6).
Putative recombination breakpoint analysis
TOPALi is graphical analysis software that uses statis-
tical analysis to detect the presence of possible recom-
bination sequences and gives an approximate location of
the breakpoints within DNA multiple alignments [34].
As described in the methods, 3' end sequences of cagA
gene of 19H. pylori sequences were aligned, and the pu-
tative recombination breakpoints were analyzed by
TOPALi (Figure 7). Using TOPALi the recombination
breakpoints are predicted at 290, 331, 381 and 447 bp.
The sequences between the putative breakpoints 291
and 331 are between Y3 and Y4 motif, and that between
381 and 447 are between Y4 and Y5 motif. The first
hypervariable region, predicted using TOPALi, includes
Y3, W1 and parts of second I2 motif. The second hype-
variable region includes I3, Y4, W1, I2, I3, Y5 and parts
of corresponding W1 motif. The predicted recombined
regions in the 3' end sequences of cagA gene may ac-
count for the sequence variation of cagA gene. Thissertions among the CagA isolated from WB, India. The segments
re the insertions have occurred are shown in bold and larger front. For
d shown in bold, larger front size and also with underscore. As shown
with the occurrence of insertions or deletions.
Figure 7 Recombination breakpoint analysis of aligned sequences of 3' end of cagA of 11H. pylori strains along with the annotated H.
pylori P12 strain using TOPALi. Numbers in bold above and below the peaks indicate the putative recombination breakpoint positions. The dotted
horizontal line is the 95 % significance point of Dss. Start of the alignment of 3’ end sequences of cagA corresponds to the 2638 bps from the
start of the cagA gene (CP001217) of H. pylori p12 strain.
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plex types of cagA genes are evolved from the CagA that
bears the core unit due to the gene conversion at the
border of the hypervariable regions.
Disease associations of the H. pylori strains are
reported to be strongly correlated with the presence of
this complex domain architecture with increasing num-
ber of repeat sequences containing EPIYA motifs of
CagA gene [25,26,30,33]. To assess the possible role of
the presence of this motif, we predicted secondary
structure of San77, which comprises of the entire five
EPIYA motifs (i.e., Y1Y2Y3Y4Y5), using Discrimination
of protein Secondary structure Class (DSC) module of
Discovery studio (Figure 8). The tyrosine residue in the
first and second EPIYA motifs are being contained in
the α-helical conformation, whereas that of the Y3, Y4
and Y5 are contained in the beta strand conformation
preceding a coil spanning from end of I2 to I3 motif.
One may hypothesize that the presence of this tyrosine
residue in the α-helical conformation may inhibit the
phosphorylation of the tyrosine residue by making it
less accessible. In contrast, the tyrosine residues in the
Y3, Y4 and Y5 motifs might be more exposed and ac-
cessible to be phosphorylated due to their presence in
β-strand conformation and the presence of preceding
loop conformation. A similar observation was alsoreported in an earlier study [35]. It could readily ex-
plain the reason why CagA proteins having more 34-
amino acid repeat sequences undergo greater tyrosine
phosphorylation and hence exhibit increased SHP-2
binding and induce greater morphological changes.
Discussion
The length polymorphism observed at the 3' end of cagA
gene of H. pylori, which results in variation in the num-
ber of phosphorylation sites of the encoded protein, is of
great interest in recent times since higher number of the
phosphorylation sites in CagA was described to be asso-
ciated with stronger biological function and disease
manifestation [25,26,30,33,36]. Several attempts have
been made to type this virulence marker considering the
variability of the phosphorylation sites (EPIYA) and cer-
tain types seem to be associated with the clinical out-
come [9,27–30,33,37,38]. However, in India, where ~85-
90 % of H. pylori strains carry the cagA gene [32], data
that relate the polymorphism at C-terminal end of the
CagA and the clinical status of the host are scanty [39].
We have found that previously described type A (type
1, in our proposed nomenclature), which is the most
prevalent CagA type in other parts of the world, was also
detected in West Bengal. However, there was no disease
association with any of the previously described CagA
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higher number of EPIYA motifs (A-B-C-C-C), which
was described to be associated with gastric cancer, was
also isolated from healthy individuals. The expression of
A-B-C-C-C type CagA in H. pylori strain isolated from
HV was also confirmed by western blot analysis. In
addition, strains isolated from healthy individuals and
those from patients with overt diseases like peptic ulcer
or gastric adenocarcinoma showed identical amino acid
repeat motifs in the CagA.
Previous reports indicate that the amino acid
sequences among the EPIYA motifs vary between West-
ern CagA and East-Asian CagA [25,26,33]. The sequence
FPLKRHDKVDDLSKV found in western type CagA
(WSS) is replaced by sequence KIASAGKGVGGFSGA
in East-Asian type CagA (ESS) and this variation in
amino acid sequences might be the reason behind the
high prevalence of gastric cancer in Japan as compared
to the West [25,30,33]. Interestingly, in this study we
have found that in Indian context, where the prevalence
of duodenal ulcer is more common than gastric cancer,
all the strains used for sequence analysis carried western
type CagA. This finding is in agreement with previous
report which describes that the conserved sequences of
cagA 5’ end region in H. pylori strains isolated from
Calcutta form cluster with cagA sequences of H. pylori
strains isolated from western countries and differ sig-
nificantly from cagA sequences found in East-Asia.
Further analysis of different CagA primary structures
revealed that the C-terminal repeat region is actually
more discrete from the previously proposed models of
CagA variants. For example, from this study it is appar-
ent that the R3 region (originally described by Yamaoka
et al for ESS), for WSS CagA, contains 3 distinct repeat
regions viz. I1, I2 and I3. The CagA primary structure
model proposed by Yamaoka et al. (1998) describes that
the R3 region is present between second and third EPIYA
motifs and also between third and fourth EPIYA motifs.
However, our analysis with strains isolated from West
Bengal and Western countries showed that although in-
tact R3 region (combination of I1-I2-I3) is present be-
tween second and third EPIYA motifs (Y2 and Y3
respectively), in type C (type 2, in the proposed nomen-
clature) only I2 and I3 is present between third and
fourth EPIYA motifs (Y3 and Y4 respectively) and I1 is
not repeated. The 34 amino acids repeat region described
by Azuma et al. (2004), which is present within third to
fifth EPIYA motifs (Y3 to Y5) can be divided as smaller
units (Figure 4). The amino acid sequence analysis of
CagA in the current study showed that this region
includes four distinct, short repeat motifs containing I2,
I3, W1 (TIDDLGGP) and Y (EPIYA). For example, in A-
B-C-C-C type CagA, I2 is repeated four times, while I3
and W1 repeated three times and after the last EPIYAmotif present in position C (Y5), I3 is replaced by T1
motif. We have noticed that T1 motif represents the ter-
mination of this repeat region for all CagA types and
after this T1 motif, no EPIYA motif was detected.
Our analysis revealed that the EPIYA motifs as well as
the spacer sequence units among the EPIYA motifs are
present as distinct insertions and deletions. For example,
between the first two EPIYA repeats, the identified re-
gion named as R2 (V1, in the proposed nomenclature)
by Yamaoka et al. (1998) for type C (type 2, in the pro-
posed nomenclature) CagA is absent in type D (type 4,
in the proposed nomenclature) CagA, although the
remaining motifs are identical. This suggests that the ab-
sence of R2 region in type 4 strains is possibly resulted
from a deletion. Many other deletions or insertions,
which we have shown in our present report, might have
occurred due to extensive genetic rearrangements or re-
combination events during the evolution. In Neisseria
gonorrhoeae for example, the pilin genes show extensive
variation at the 3' end while the 5' end remain relatively
conserved and undergo recombination in order to gen-
erate antigenic variation of pilin expression [24]. This
reassortment of pilin genes in this organism occurs pos-
sibly by two distinct mechanisms [40]. Both piliated and
revertible P- cells of N. gonorrhoeae are competent for
in vitro DNA uptake during autolysis. This mechanism
suggests that pilin antigenic variation occurs through
transformation by exogenous DNA liberated from lysed
cells within a population [41]. In addition to this, trans-
formation-mediated recombination and intragenomic re-
ciprocal recombination also contribute to the pilin
antigenic variation [40]. Likewise, H. pylori is also natur-
ally competent [42], undergoes autolysis [43] and the
frequency of recombination in this species is very high
[44]. This indicates that transformation-mediated re-
combination might be responsible for the extensive var-
iations observed at the 3' end of cagA gene. Moreover,
the cagPAI contains genes that code for a putative type
IV pilus, which is involved in CagA translocation to the
host cell could also be involved in the DNA uptake
[12,14–16]. Intragenomic reciprocal recombination be-
tween two cagA loci of the same chromosome is also
possible as multiple H. pylori strains were isolated from
single gastric niche, which had identical DNA fingerprint
with polymorphism only at the 3' end repeat region of
cagA (unpublished data). It is important to mention here
that the CagA, apart from SHP2, interacts with several
other proteins, which are important for cell cycle regula-
tion and EPIYA motifs, in phosphorylated as well as
unphosphorylated form, are possibly the active sites of
CagA [23,45,46]. Therefore, recombination in these sites
is possibly important for H. pylori to manifest different
levels of biological activity in order to survive in human
gastric mucosa- an environment, which changes often
Figure 8 Secondary structure cartoon of San77 predicted using Discrimination of protein Secondary structure Class (DSC) in Discovery
studio (Accelrys, USA). Helices are colored in red, strands are in blue, and coils are in beige. Tyrosine residues in first and second EPIYA motifs
are within the alpha-helical region. Tyrosine residues in third, fourth and fifth ‘EPIYA’ motifs are within the beta-strands.
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in these repeats should also result in variation in three-
dimensional structure of CagA protein. These structural
changes, apart from the variability in biological function
in terms of interfering with several signaling pathways,
might result in minute changes in antigenicity, which is
possibly necessary for the pathogen to escape host im-
mune surveillance, considering the CagA is a highly
immunodominant protein. Therefore, H. pylori strains,
under continuous selection pressure, may recombine
with high efficiency during prolonged colonization in
gastric mucosa resulting emergence of different CagA
types.Conclusions
In Summary, we have identified seven CagA types and
several of them are being reported for the first time in-
cluding a CagA type, which carry a single EPIYA motif.
These new CagA structures could not be typed by the
existing systems and therefore, we have proposed a new
typing system. Although this typing system is developed
by analyzing CagA primary structures of H. pylori strains
isolated in West Bengal, India, we have noticed that it is
suitable to type all CagA primary structures having WSS
detected in other parts of the world. Previously, it was
shown by Higashi et al (2002) that tyrosine phosphoryl-
ation at C position is necessary and sufficient for CagA-
SHP2 complex formation and the tyrosine residues at A
and B positions have little functional significance. We
have identified two strains, which carry CagA with
EPIYA motifs present at A and B positions (Y1 and Y2
respectively) only but lack the same motif at C position
(Y3) as this region is found to be absent due to natural
deletion. Interestingly, one of these two strains was iso-
lated from a patient with gastric adenocarcinoma. More-
over, we have found that the H. pylori strain (San 77)
isolated from healthy individual can express A-B-C-C-C
type CagA. Thus, our data strongly indicate that carrying
a particular type of CagA is not the only determinant forthe disease outcome especially in the developing coun-
tries like India, where multiple infections with different
CagA primary structures are possible (unpublished data).
We believe that CagA status of the infected H. pylori
strains as well as other factors must contribute to cause
disease and host genetic traits are the most important
among them.
Materials and methods
Patient samples and H. pylori strains
A total of 77H. pylori strains, 40 from DU, 20 from HV,
15 from NUD and 2 from GC were isolated as described
earlier [11,32]. In brief, these individuals underwent a
non-sedated upper gastrointestinal endoscopy (GIF XQ
30, Olympus Optical Company, Japan) under topical lig-
nocaine anesthesia at the Hospital of the Institute of
Post Graduate Medical Education and Research in Kol-
kata, India. Written informed consent was obtained
from each of these individuals as per the recommenda-
tions of the Ethical Committee of the Institute of Post
Graduate Medical Education and Research and the study
was ethically approved by the committee. Gastric biopsy
specimens were transported in 1 ml of Brucella broth
(Becton Dickinson, Sparks, MD, USA) containing 15 %
of glycerol in cold condition for culture at the Helico-
bacter unit of the National Institute of Cholera and En-
teric Diseases. H. pylori was isolated from biopsy
specimens, sub-cultured and preserved at −70°C in brain
heart infusion (BHI) (BD) containing 15 % glycerol as
described earlier [11,32].
Characterization of H. pylori strains by PCR
H. pylori genomic DNA was extracted by CTAB (hexa-
decyltrimethyl ammonium bromide) method [47] from
confluent lawn of bacterial culture on BHI agar (BD)
plate. All the strains included in this study carried cagA
gene as determined previously by PCR using primers
designed from 5' end conserved regions [32,48].
Genomic DNA extracted from these strains was used to
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(5'–ACCCTAGTCGGTAATGGGTTA-3') and CAG2
(5'–GTAATTGTCTAGTTTCGC-3') [30].
Nucleotide sequencing of PCR products and sequence
analysis
PCR products were purified by QIAquick PCR purifica-
tion kit (Qiagen GmbH, Hilden, Germany) and used dir-
ectly as a template for nucleotide sequencing. Both
strands of DNA were sequenced with the Big-dye ter-
minator cycle sequencing kit (Applied Biosystems, Foster
city, CA) according to the manufacturer’s instructions,
using an ABI PRISM 310 sequencer (Applied Biosys-
tems). The nucleotide and deduced amino acid
sequences were edited and compared after aligning using
SeqMan and EditSeq program of DNASTAR (DNAS-
TAR, Inc). Multiple alignments were done by using
ClustalW in MegAlign software (DNASTAR, Inc.). Fi-
nally, the discrete motifs present at the C-terminal end
of the CagA were identified by manual analysis.
Western blotting
H. pylori strains cultured on BHI agar were harvested in
phosphate-buffered saline (PBS), and subjected to SDS-
PAGE followed by transfer to nitrocellulose membrane.
Proteins immobilized on membrane were incubated with
anti-CagA antibody (Austral biologicals, CA) diluted
1:4000 in Tris buffer saline containing 3 % bovine serum
albumin and 1 % tween-20 for 1 hr, washed and incu-
bated with anti-rabbit antibody (Santa Cruz Biotech.,
CA) for 1 hr. After washing immunoreactive components
were visualized by ECL detection system (Amersham).
Nucleotide sequence accession numbers
The nucleotide sequences of the 3' end of cagA gene of
21H. pylori strains were deposited in GenBank under the
following accession numbers: EU089757 to EU089775,
EU368669 and EU368670.
Sequence and putative recombination breakpoint
analysis
To predict the cagA recombination sites, the 3' end
sequences of cagA gene of 21H. pylori strains were
aligned in ClustalW [49] and some manual corrections
were made to achieve accurate alignment. The aligned
sequences were analyzed by the TOPALi software. The
detailed description of the algorithm of TOPALi software
was available elsewhere [34,50,51]. Briefly, the pairwise
distance matrix of the aligned sequences was calculated
using the Jukes-Cantor nucleotide substitution model. A
window i of user-defined length was moved forward and
backward along the sequence alignment at a certain step-
wise intervals. For each window i, the difference of sums
of squares of forward (DssiF) and backward (Dss
i
B)windows were calculated. The corresponding Dss value
was obtained using from the maximum of DssiF and Dss
i
B.
Dss values were plotted for each window. A set of adja-
cent large Dss values forming a significant peak sug-
gested a putative recombination breakpoint.
Competing interests
The authors declare that they have no competing interests.
Acknowledgement
The work was supported in part by the Indian Council of Medical Research
and Japan Initiative for Global Research Network on Infectious Diseases (J-
GRID) Ministry of Education, Culture, Sports, Science and Technology of
Japan.
Author details
1National Institute of Cholera and Enteric Diseases, Kolkata, 700010, India.
2Centre for Liver Research School of Digestive and Liver Diseases, Institute of
Post Graduate Medical Education & Research, Kolkata, India. 3Washington
University School of Medicine, Saint Louis, USA. 4Division of Bacteriology,
National Institute of Cholera and Enteric Diseases, P 33 CIT Road Scheme XM,
Beliaghata, Kolkata, 700010, India.
Authors’ contributions
SC and AKM conceived of the study, GBN, TR and DEB participated in the
design of this study; AC, SC and RP coordinated collection of specimens,
maintenance of clinical data and management of patients; SC, RP, RC, RD
and JA carried out bacterial isolation and bacterial sequencing and sequence
analysis using different soft wares. All authors read and approved the final
manuscript.
Received: 4 April 2012 Accepted: 25 May 2012
Published: 25 May 2012
References
1. Blaser MJ: Helicobacter pylori and the pathogenesis of gastroduodenal
inflammation. J Infect Dis 1990, 161:626–633.
2. Peek RM Jr, Blaser MJ: Helicobacter pylori and gastrointestinal tract
adenocarcinomas. Nat Rev Cancer 2002, 2:28–37.
3. Cover TL, Dooley CP, Blaser MJ: Characterization of and human
serologic response to proteins in Helicobacter pylori broth culture
supernatants with vacuolizing cytotoxin activity. Infect Immun 1990,
58:603–610.
4. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI,
Blaser MJ: Serologic detection of infection with cagA+Helicobacter pylori
strains. J Clin Microbiol 1995, 33:1496–1500.
5. Gerstenecker B, Eschweiler B, Vogele H, Koch HK, Hellerich U, Kist M:
Serodiagnosis of Helicobacter pylori infections with an enzyme
immunoassay using the chromatographically purified 120 kilodalton
protein. Eur J Clin Microbiol Infect Dis 1992, 11:595–601.
6. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL:
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori.
Association of specific vacA types with cytotoxin production and peptic
ulceration. J Biol Chem 1995, 270:17771–17777.
7. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH,
Stemmermann GN, Nomura A: Infection with Helicobacter pylori
strains possessing cagA is associated with an increased risk of
developing adenocarcinoma of the stomach. Cancer Res 1995,
55:2111–2115.
8. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli
R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes
type I-specific and disease-associated virulence factors. Proc Natl Acad Sci
U S A 1996, 93:14648–14653.
9. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone
A, Papini E, Xiang Z, Figura N, et al: Molecular characterization of the
128-kDa immunodominant antigen of Helicobacter pylori associated
with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993,
90:5791–5795.
Chattopadhyay et al. Gut Pathogens 2012, 4:4 Page 11 of 12
http://www.gutpathogens.com/content/4/1/410. Parsonnet J, Friedman GD, Orentreich N, Vogelman H: Risk for gastric
cancer in people with CagA positive or CagA negative Helicobacter pylori
infection. Gut 1997, 40:297–301.
11. Chattopadhyay S, Datta S, Chowdhury A, Chowdhury S, Mukhopadhyay AK,
Rajendran K, Bhattacharya SK, Berg DE, Nair GB: Virulence genes in
Helicobacter pylori strains from West Bengal residents with overt H.
pylori-associated disease and healthy volunteers. J Clin Microbiol 2002,
40:2622–2625.
12. Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR,
Naumann M, Meyer TF: Translocation of the Helicobacter pylori CagA
protein in gastric epithelial cells by a type IV secretion apparatus. Cell
Microbiol 2000, 2:155–164.
13. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R: Translocation
of Helicobacter pylori CagA into gastric epithelial cells by type IV
secretion. Science 2000, 287:1497–1500.
14. Rohde M, Puls J, Buhrdorf R, Fischer W, Haas R: A novel sheathed surface
organelle of the Helicobacter pylori cag type IV secretion system. Mol
Microbiol 2003, 49:219–234.
15. Tanaka J, Suzuki T, Mimuro H, Sasakawa C: Structural definition on the
surface of Helicobacter pylori type IV secretion apparatus. Cell Microbiol
2003, 5:395–404.
16. Yeo HJ, Savvides SN, Herr AB, Lanka E, Waksman G: Crystal structure of the
hexameric traffic ATPase of the Helicobacter pylori type IV secretion
system. Mol Cell 2000, 6:1461–1472.
17. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M: Structural basis and
functional consequence of Helicobacter pylori CagA multimerization in
cells. J Biol Chem 2006, 281:32344–32352.
18. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: Src is the kinase of the
Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002,
277:6775–6778.
19. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A: c-Src/Lyn
kinases activate Helicobacter pylori CagA through tyrosine
phosphorylation of the EPIYA motifs. Mol Microbiol 2002, 43:971–980.
20. Stein M, Rappuoli R, Covacci A: Tyrosine phosphorylation of the
Helicobacter pylori CagA antigen after cag-driven host cell translocation.
Proc Natl Acad Sci U S A 2000, 97:1263–1268.
21. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama
M: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter
pylori CagA protein. Science 2002, 295:683–686.
22. Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M, Azuma
T: The CagA protein of Helicobacter pylori is translocated into epithelial
cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 2003,
187:334–337.
23. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S:
Disruption of the epithelial apical-junctional complex by Helicobacter
pylori CagA. Science 2003, 300:1430–1434.
24. Saunders JR: Bacterial pathogenicity: molecular auspects. In The
encyclopedia of molecular biology. Edited by Kendrew J. Oxford, Great
Britain: Blackwell science; 1994:101–104.
25. Azuma T: Helicobacter pylori CagA protein variation associated with
gastric cancer in Asia. J Gastroenterol 2004, 39:97–103.
26. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, Ito Y,
Dojo M, Yamazaki Y, Kuriyama M, et al: Association between diversity in
the Src homology 2 domain–containing tyrosine phosphatase binding
site of Helicobacter pylori CagA protein and gastric atrophy and cancer.
J Infect Dis 2004, 189:820–827.
27. Argent RH, Zhang Y, Atherton JC: Simple method for determination
of the number of Helicobacter pylori CagA variable-region EPIYA
tyrosine phosphorylation motifs by PCR. J Clin Microbiol 2005,
43:791–795.
28. Dong Q, O'Sullivan M, Hall W, Herra C, Kean C, O'Morain C, Buckley
M: Identification of a new segment involved in cagA 3' region
variation of Helicobacter pylori. FEMS Immunol Med Microbiol 2002,
33:51–55.
29. Owen RJ, Sharp SI, Chisholm SA, Rijpkema S: Identification of cagA
tyrosine phosphorylation DNA motifs in Helicobacter pylori isolates
from peptic ulcer patients by novel PCR-restriction fragment length
polymorphism and real-time fluorescence PCR assays. J Clin Microbiol
2003, 41:3112–3118.
30. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR: Variants of
the 3' region of the cagA gene in Helicobacter pylori isolates frompatients with different H. pylori-associated diseases. J Clin Microbiol 1998,
36:2258–2263.
31. Rota CA, Pereira-Lima JC, Blaya C, Nardi NB: Consensus and variable
region PCR analysis of Helicobacter pylori 3' region of cagA gene in
isolates from individuals with or without peptic ulcer. J Clin Microbiol
2001, 39:606–612.
32. Mukhopadhyay AK, Kersulyte D, Jeong JY, Datta S, Ito Y, Chowdhury A,
Chowdhury S, Santra A, Bhattacharya SK, Azuma T, et al: Distinctiveness of
genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 2000,
182:3219–3227.
33. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama
M: Biological activity of the Helicobacter pylori virulence factor CagA is
determined by variation in the tyrosine phosphorylation sites. Proc Natl
Acad Sci U S A 2002, 99:14428–14433.
34. McGuire G, Wright F, Prentice MJ: A graphical method for detecting
recombination in phylogenetic data sets. Mol Biol Evol 1997, 14:1125–
1131.
35. Ma Y, Cunningham ME, Wang X, Ghosh I, Regan L, Longley BJ: Inhibition of
Spontaneous Receptor Phosphorylation by Residues in a Putative
/−Helix in the KIT Intracellular Juxtamembrane Region. J Biol Chem
1999, 274:13399–13402.
36. Zhang Y, Argent RH, Letley DP, Thomas RJ, Atherton JC: Tyrosine
phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS
gastric epithelial cells. J Clin Microbiol 2005, 43:786–790.
37. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC:
Determinants and consequences of different levels of CagA
phosphorylation for clinical isolates of Helicobacter pylori.
Gastroenterology 2004, 127:514–523.
38. Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T,
Kashima K, Graham DY: Relationship between the cagA 3' repeat region
of Helicobacter pylori, gastric histology, and susceptibility to low pH.
Gastroenterology 1999, 117:342–349.
39. Tiwari SK, Sharma V, Sharma VK, Gopi M, Saikant R, Nandan A, Bardia A,
Gunisetty S, Katikala P, Habeeb MA, Khan AA, Habibullah CM: Phylogenetic
analysis, based on EPIYA repeats in the cagA gene of Indian Helicobacter
pylori, and the implications of sequence variation in tyrosine
phosphorylation motifs on determining the clinical outcome. Genet Mol
Biol 2011, 34:280–285.
40. Gibbs CP, Reimann BY, Schultz E, Kaufmann A, Haas R, Meyer TF:
Reassortment of pilin genes in Neisseria gonorrhoeae occurs by two
distinct mechanisms. Nature 1989, 338:651–652.
41. Seifert HS, Ajioka RS, Marchal C, Sparling PF, So M: DNA transformation
leads to pilin antigenic variation in Neisseria gonorrhoeae. Nature 1988,
336:392–395.
42. Nedenskov-Sorensen P, Bukholm G, Bovre K: Natural competence for
genetic transformation in Campylobacter pylori. J Infect Dis 1990,
161:365–366.
43. Marsich E, Zuccato P, Rizzi S, Vetere A, Tonin E, Paoletti S: Helicobacter
pylori expresses an autolytic enzyme: gene identification, cloning, and
theoretical protein structure. J Bacteriol 2002, 184:6270–6279.
44. Suerbaum S, Smith JM, Bapumia K, Morelli G, Smith NH, Kunstmann E, Dyrek
I, Achtman M: Free recombination within Helicobacter pylori. Proc Natl
Acad Sci U S A 1998, 95:12619–12624.
45. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C: Grb2 is a key
mediator of Helicobacter pylori CagA protein activities. Mol Cell 2002,
10:745–755.
46. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H,
Ohnishi N, Azuma T, Suzuki A, Ohno S, Hatakeyama M: Helicobacter pylori
CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature
2007, 447:330–333.
47. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, et al: Current
protocols in molecular biology. New York: Greene Publishing and Wiley-
Interscience; 1993.
48. Chattopadhyay S, Patra R, Ramamurthy T, Chowdhury A, Santra A, Dhali GK,
Bhattacharya SK, Berg DE, Nair GB, Mukhopadhyay AK: Multiplex PCR assay
for rapid detection and genotyping of Helicobacter pylori directly from
biopsy specimens. J Clin Microbiol 2004, 42:2821–2824.
49. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through
sequence weighting, position-specific gap penalties and weight matrix
choice. Nucleic Acids Res 1994, 22:4673–4680.
Chattopadhyay et al. Gut Pathogens 2012, 4:4 Page 12 of 12
http://www.gutpathogens.com/content/4/1/450. McGuire G, Wright F: TOPAL: recombination detection in DNA and
protein sequences. Bioinformatics 1998, 14:219–220.
51. McGuire G, Wright F: TOPAL 2.0: improved detection of mosaic
sequences within multiple alignments. Bioinformatics 2000,
16:130–134.
doi:10.1186/1757-4749-4-4
Cite this article as: Chattopadhyay et al.: Distinct repeat motifs at the
C-terminal region of CagA of Helicobacter pylori strains isolated from
diseased patients and asymptomatic individuals in West Bengal,
India. Gut Pathogens 2012 4:4.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
